Facebook LinkedIn YouTube Twitter
Kaplain-Meier analysis of time from extubation to reintubation graph

'Use of NHF reduced the risk of reintubation within 72 hours.'

(among extubated patients at low risk for reintubation)

~ Hernández et al. JAMA. 2016.


 
Reduced 90 day mortality and reduced intubation rate graphs

NHF significantly reduced need for intubation in more acute patients

(compared to standard O2 and NIV,
PaO2:FiO2 ≤ 200 mmHg)

~ Frat et al. New Engl J Med. 2015.
 

Medical staff with Nasal High Flow male patient

NHF was found
non-inferior to BPAP

(among cardiothoracic surgery patients with or at risk for respiratory failure)

~ Stéphan et al. JAMA. 2015

Reduces escalation of care

Pre-intubation: 

  • Significantly reduces intubation rate when PaO2:FiO2 ≤200 mm Hg 
        Frat et al. New Engl
        J Med. 2015.


Post-Extubation:

  • Reduces escalation to non-invasive ventilation and re-intubation
         Parke et al. Respir
         Care. 2011.
         Hernández et al.
         JAMA. 2016. 
 
  • Non-inferior to Bi-level Positive Airway Pressure
         Stéphan et al.
         JAMA. 2015.

Improves symptomatic relief

  • Significantly reduced intensity of respiraotry discomfort and dyspnea
         Frat et al. New Engl J
         Med 2015. 
​  
  • Rapid and sustained improvement of dyspnea in patients with respiratory distress in the emergency department  
         Lenglet et al. 
         Respir Care. 2012. 

Improves patient comfort

  • Well tolerated
          Sztrymf et al. Intensive
          Care Medicine. 2011. 
 
  • Greater overall comfort than face mask
          Roca et al.
          Respir Care.2010. 
          Lenglet et al.
          Respir Care. 2012. 
 

 

Resources

Optiflow Adult Clinical Paper Summaries

(PDF 0.8MB)

Download

Optiflow Therapy Brochure

(PDF 0.9MB)

Download

Optiflow Flow Matters Newsletter - Issue 8

(PDF 0.1MB)

Download

 

Please enter your details below and an F&P representative will contact you.
Contact Details
Please select from the following options:*

By submitting your personal information, you are consenting to F&P Healthcare storing your personal information to contact you regarding your enquiry. Please note, F&P will not share or disclose your information to other third parties for marketing purposes. We may share your personal data with our group company headquarters in New Zealand. For information about how we use and manage your personal information, your rights to access, correct or delete your personal information, and how to contact us about your personal information, please see our privacy statement.

Want to receive updates?

Sign up to receive email notifications of the latest product and therapy information as well as upcoming events.
 

Sign up here